Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant in Prader-Willi Syndrome
NCT06366464Phase 3Recruiting
- Sponsor
- Harmony Biosciences
- Start
- May 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of pitolisant in Prader-Willi syndrome (PWS), sponsored by Harmony Biosciences. Started May 2024; status: recruiting.
02
Drugs
pitolisant
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT06366464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06366464.